We are live on ! Find out more
Allspring Global Investments

Allspring Global Investments Portfolio holdings

AUM $65.2B
1-Year Est. Return 39.42%
This Fund
S&P 500
This Quarter Est. Return
+1.39%
1 Year Est. Return
+39.42%
3 Year Est. Return
+106.84%
5 Year Est. Return
10 Year Est. Return
AUM
$61.3B
AUM Growth
-$2.74B
Cap. Flow
-$2.2B
Cap. Flow %
-3.59%
Top 10 Hldgs %
14.45%
Holding
2,566
New
269
Increased
893
Reduced
1,095
Closed
190

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Industrials 14.2%
3 Financials 11.99%
4 Consumer Discretionary 10.18%
5 Healthcare 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCGO icon
1776
DocGo
DCGO
$64.5M
$147K ﹤0.01%
+47,480
New +$156K
HLN icon
1777
Haleon
HLN
$43.2B
$146K ﹤0.01%
17,704
+12,637
+249% +$106K
XLB icon
1778
State Street Materials Select Sector SPDR ETF
XLB
$8.57B
$145K ﹤0.01%
3,290
+2,152
+189% +$97.3K
HCC icon
1779
Warrior Met Coal
HCC
$4.98B
$145K ﹤0.01%
2,313
+599
+35% +$38.8K
WEAV icon
1780
Weave Communications
WEAV
$426M
$145K ﹤0.01%
+16,092
New +$157K
JWN
1781
DELISTED
Nordstrom
JWN
$143K ﹤0.01%
6,739
-85
-1% -$1.74K
APGE icon
1782
Apogee Therapeutics
APGE
$10.2B
$143K ﹤0.01%
+3,629
New +$176K
RYZ
1783
Ryerson Holding Corp
RYZ
$1.5B
$143K ﹤0.01%
7,322
-6,278
-46% -$162K
PHG icon
1784
Philips
PHG
$26.8B
$143K ﹤0.01%
6,115
+3,876
+173% +$87.1K
LAUR icon
1785
Laureate Education
LAUR
$5.15B
$142K ﹤0.01%
9,515
+5,626
+145% +$84.2K
DNLI icon
1786
Denali Therapeutics
DNLI
$3.97B
$142K ﹤0.01%
6,097
-63
-1% -$1.21K
RM icon
1787
Regional Management Corp
RM
$301M
$141K ﹤0.01%
4,919
+4,913
+81,883% +$133K
AM icon
1788
Antero Midstream
AM
$10.5B
$141K ﹤0.01%
9,583
+7,343
+328% +$105K
CCRD
1789
DELISTED
CoreCard
CCRD
$141K ﹤0.01%
9,677
-734
-7% -$9.65K
JHX icon
1790
James Hardie Industries
JHX
$17.9B
$141K ﹤0.01%
4,475
+2,726
+156% +$93.8K
TAK icon
1791
Takeda Pharmaceutical
TAK
$55.5B
$141K ﹤0.01%
10,907
+3,143
+40% +$41.6K
CTKB icon
1792
Cytek Biosciences
CTKB
$636M
$140K ﹤0.01%
+25,144
New +$151K
INMD icon
1793
InMode
INMD
$875M
$137K ﹤0.01%
7,517
-128
-2% -$2.35K
RARE icon
1794
Ultragenyx Pharmaceutical
RARE
$2.6B
$137K ﹤0.01%
3,331
+13
+0.4% +$555
BAM icon
1795
Brookfield Asset Management
BAM
$89.2B
$137K ﹤0.01%
3,588
+186
+5% +$7.31K
IART icon
1796
Integra LifeSciences
IART
$1.42B
$136K ﹤0.01%
4,662
+1,711
+58% +$50.7K
MPLX icon
1797
MPLX
MPLX
$59.6B
$134K ﹤0.01%
3,158
CBAN icon
1798
Colony Bankcorp
CBAN
$471M
$134K ﹤0.01%
10,926
-3,564
-25% -$40.6K
CNK icon
1799
Cinemark Holdings
CNK
$4.37B
$131K ﹤0.01%
6,061
+210
+4% +$3.81K
NAPA
1800
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$130K ﹤0.01%
18,267
-189
-1% -$1.52K

Similar funds

Allspring Global Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Allspring Global Investments held 2,566 positions worth $61.3B, down 4.3% from $64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Allspring Global Investments withdrew a net $2.2B in Q2 2024, closing 190 positions and reducing 1,095 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $168M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

Against the trend, Allspring Global Investments opened a new position in Franco-Nevada worth $19.4M.

  • Allspring Global Investments's largest Q2 2024 buy was Franco-Nevada: 2,332,483 shares worth $19.4M.
  • Allspring Global Investments added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $116M increase.
  • Allspring Global Investments's biggest Q2 2024 reduction was Carlisle Companies, cutting an estimated $171M.
  • Allspring Global Investments fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $168M.
  • Allspring Global Investments's ten largest holdings make up 14% of its $61.3B portfolio in Q2 2024.
  • Allspring Global Investments opened 269 new positions and closed 190 in Q2 2024.
  • Allspring Global Investments's portfolio value fell 4.3% quarter-over-quarter to $61.3B.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.